Nursing Review Issue 6 November-December 2022 | Page 24

clinical practice
clinical practice

From the heart

Dwindling heart research pipeline may be at risk .
By Elise Hartevelt

Cardiology research is facing a substantial loss of expertise due to a lack of funding for basic science , according to researchers .

Cardiovascular disease ( CVD ) is a major contributor to Australia ’ s overall disease burden . It remains the leading cause of death and morbidity worldwide .
One in twenty deaths is caused by heart attacks in Australia , with nineteen people dying from CVD daily .
Associate Professor Mary Kavurma from the Heart Research Institute worries that reduced cardiac research will lead to fewer breakthroughs in heart disease treatment . “ It ’ s a huge issue ,” Kavurma says . “ Medical research is like a pipeline , moving research ideas from discovery to implementation at patients ’ bedsides .”
“ Without basic science , there are no medical breakthroughs , yet today we see a significant decline in funding and support for the researchers .”
22 | nursingreview . com . au
CVD is ranked as our healthcare ’ s second highest expenditure – 8.7 per cent of Australia ’ s health system ’ s total costs are spent on CVD treatment , accounting for $ 11.8 billion .
The most costly heart conditions are coronary heart disease ($ 2.4 billion ) and atrial fibrillation ($ 1.2 billion ).
Kavurma says that symptoms often go unnoticed and is a major contributor to CVD ’ s high number of hospitalisations .
“ Many people don ’ t know they are living with a heart disease until they have their first stroke ,” she says .
“ There ’ s so much researchers and frontline healthcare workers don ’ t understand when diagnosing and treating heart conditions .”
“ It ’ s central and fundamental to form new treatments and interventions , for which you need research and evidence .”
On September 29th , the government announced that they ’ d allocate $ 156 million in funding towards medical research , with ($ 33.6 million ) going towards 41 heart health projects .
Although Kavurma says she welcomes the funding , it doesn ’ t solve the issue of scientists leaving the field .
“ Today we see a significant decline in funding and support for the researchers .
People who pursue other types of research , such as longitudinal and explanatory studies , rely on private or philanthropic organisations for funding .
Kavurma says the grant funding success rate is about 10 percent , so the industry is facing a massive loss of expertise .
Dr Belinda Dibartolo is one such researcher , who after 20 years in cardiovascular research now works as a Chief Operations Officer for an Australasian biotech company .
“ You ’ ve got to live and die by your next grant . I loved what I was doing . Let ’ s face it , you don ’ t go into research for the money , you do it because you are passionate about it ,” Dibartolo said . “ I dedicated my life and soul to research , but stepping away was the hardest decision and I felt like I ’ d thrown away 20 years of my life , but without grants you have no research .” ■